Jennifer Capasso had endured multiple tumors. She wondered what might be said during her next cancer surgery. So, she hit ...

A new study published in the Journal of Clinical Investigation has identified biomarkers that predict the likelihood of a patient developing checkpoint inhibitor-associated autoimmune diabetes before ...

A 46-year-old man with advanced lung cancer recovered after doctors used Next Generation Sequencing to identify a rare ALK ...

Diffuse large B-cell lymphoma (DLBCL) is an aggressive blood cancer that kills most untreated patients within one year. Standard CHOP chemotherapy improves five-year survival to 70%—still a ...

Take Action on Radon is a national initiative funded by Health Canada that works to bring together radon stakeholders and raise radon awareness across Canada. The initiative is led by the Canadian ...

Homeless Phoenix man finds hope and healing at a medical respite center, overcoming substance abuse and regaining self-worth.

Lung Cancer Awareness Month highlights the importance of staying informed about advancements, screening, and preventive ...

Dr. Daniel J. Boffa discusses advancements in lung cancer care, including the role of minimally invasive surgical techniques and new systemic therapies.

Bailey is a 16-year-old high school basketball player in Lebanon, Tenn., who was given two weeks to live, six weeks ago.

The research highlights the role of immune checkpoint inhibitors, drugs that enhance the body's ability to fight tumors.

The subcutaneous formulation of toripalimab demonstrated noninferior pharmacokinetics compared to the intravenous version in ...

Comprehensive biomarker testing is central to the management of metastatic non-small cell lung cancer (NSCLC). Widespread ...